Contact
Please use this form to send email to PR contact of this press release:
Nightstar Therapeutics Announces Initiation of STAR Phase 3 Registrational Trial for NSR-REP1 in Choroideremia
TO:
Please use this form to send email to PR contact of this press release:
Nightstar Therapeutics Announces Initiation of STAR Phase 3 Registrational Trial for NSR-REP1 in Choroideremia
TO: